Paradigm BioCapital Advisors

Paradigm BioCapital Advisors is a New York-based hedge fund and investment advisory firm specializing in the life sciences sector. The company focuses on investing in transformative therapeutics and provides strategic advisory services to biotech, pharmaceutical, and healthcare companies. It manages a diversified portfolio of public and private investments across the biotechnology and pharmaceutical industries, with assets under management exceeding $2 billion as of March 2025. The firm's investments include stakes in innovative drug development companies at various clinical stages but it does not itself conduct drug discovery or development.